January 25, 2015 9:34 PM ET


Company Overview of Neurotune AG

Company Overview

Neurotune AG discovers and develops therapeutics for the treatment of neuromuscular and central nervous system disorders. The company develops medications for neuropathic pain and sarcopenia (age-related loss of muscle mass and strength). It also develops a platform for the diagnosis and treatment of sarcopenia, as well as a diagnostic immunoassay to measure CAF levels in blood samples. The company was founded in 2005 and is based in Schlieren, Switzerland with an additional office in Bioggio (Ticino), Switzerland.

Wagistrasse 27 a

Schlieren,  8952


Founded in 2005


41 44 200 21 95


41 44 200 20 80

Key Executives for Neurotune AG

Chief Executive Officer and Chief Financial Officer
Chairman of the Board and Head of BD & L
Head of R&D
Chief Scientific Officer
Age: 54
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Debiopharm S.A. Europe
Serono Technologies S.A. Europe
Bogar AG Europe
Metriopharm AG Europe
Abbott Products Operations AG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neurotune AG, please visit www.neurotune.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.